Prospective isolation of chondroprogenitors from human iPSCs based on cell surface markers identified using a CRISPR-Cas9-generated reporter.
Cartilage
Chondrocyte
Chondroprogenitor
Differentiation
Single-cell RNA sequencing
Surface markers
hiPSC
Journal
Stem cell research & therapy
ISSN: 1757-6512
Titre abrégé: Stem Cell Res Ther
Pays: England
ID NLM: 101527581
Informations de publication
Date de publication:
18 02 2020
18 02 2020
Historique:
received:
08
07
2019
accepted:
11
02
2020
revised:
05
02
2020
entrez:
20
2
2020
pubmed:
20
2
2020
medline:
16
3
2021
Statut:
epublish
Résumé
Articular cartilage shows little or no capacity for intrinsic repair, generating a critical need of regenerative therapies for joint injuries and diseases such as osteoarthritis. Human-induced pluripotent stem cells (hiPSCs) offer a promising cell source for cartilage tissue engineering and in vitro human disease modeling; however, off-target differentiation remains a challenge during hiPSC chondrogenesis. Therefore, the objective of this study was to identify cell surface markers that define the true chondroprogenitor population and use these markers to purify iPSCs as a means of improving the homogeneity and efficiency of hiPSC chondrogenic differentiation. We used a CRISPR-Cas9-edited COL2A1-GFP knock-in reporter hiPSC line, coupled with a surface marker screen, to identify a novel chondroprogenitor population. Single-cell RNA sequencing was then used to analyze the distinct clusters within the population. An unpaired t test with Welch's correction or an unpaired Kolmogorov-Smirnov test was performed with significance reported at a 95% confidence interval. Chondroprogenitors expressing CD146, CD166, and PDGFRβ, but not CD45, made up an average of 16.8% of the total population. Under chondrogenic culture conditions, these triple-positive chondroprogenitor cells demonstrated decreased heterogeneity as measured by single-cell RNA sequencing with fewer clusters (9 clusters in unsorted vs. 6 in sorted populations) closer together. Additionally, there was more robust and homogenous matrix production (unsorted: 1.5 ng/ng vs. sorted: 19.9 ng/ng sGAG/DNA; p < 0.001) with significantly higher chondrogenic gene expression (i.e., SOX9, COL2A1, ACAN; p < 0.05). Overall, this study has identified a unique hiPSC-derived subpopulation of chondroprogenitors that are CD146
Sections du résumé
BACKGROUND
Articular cartilage shows little or no capacity for intrinsic repair, generating a critical need of regenerative therapies for joint injuries and diseases such as osteoarthritis. Human-induced pluripotent stem cells (hiPSCs) offer a promising cell source for cartilage tissue engineering and in vitro human disease modeling; however, off-target differentiation remains a challenge during hiPSC chondrogenesis. Therefore, the objective of this study was to identify cell surface markers that define the true chondroprogenitor population and use these markers to purify iPSCs as a means of improving the homogeneity and efficiency of hiPSC chondrogenic differentiation.
METHODS
We used a CRISPR-Cas9-edited COL2A1-GFP knock-in reporter hiPSC line, coupled with a surface marker screen, to identify a novel chondroprogenitor population. Single-cell RNA sequencing was then used to analyze the distinct clusters within the population. An unpaired t test with Welch's correction or an unpaired Kolmogorov-Smirnov test was performed with significance reported at a 95% confidence interval.
RESULTS
Chondroprogenitors expressing CD146, CD166, and PDGFRβ, but not CD45, made up an average of 16.8% of the total population. Under chondrogenic culture conditions, these triple-positive chondroprogenitor cells demonstrated decreased heterogeneity as measured by single-cell RNA sequencing with fewer clusters (9 clusters in unsorted vs. 6 in sorted populations) closer together. Additionally, there was more robust and homogenous matrix production (unsorted: 1.5 ng/ng vs. sorted: 19.9 ng/ng sGAG/DNA; p < 0.001) with significantly higher chondrogenic gene expression (i.e., SOX9, COL2A1, ACAN; p < 0.05).
CONCLUSIONS
Overall, this study has identified a unique hiPSC-derived subpopulation of chondroprogenitors that are CD146
Identifiants
pubmed: 32070421
doi: 10.1186/s13287-020-01597-8
pii: 10.1186/s13287-020-01597-8
pmc: PMC7026983
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
66Subventions
Organisme : NIAMS NIH HHS
ID : K99 AR075899
Pays : United States
Organisme : NIAMS NIH HHS
ID : R00 AR075899
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007171
Pays : United States
Références
Acta Histochem. 2008;110(5):397-407
pubmed: 18272209
Aging (Albany NY). 2011 Oct;3(10):920-33
pubmed: 21990129
Elife. 2014 Sep 25;3:e03696
pubmed: 25255216
J Mater Sci Mater Med. 2008 Jul;19(7):2563-7
pubmed: 17665108
J Anat. 1996 Aug;189 ( Pt 1):9-22
pubmed: 8771392
Osteoarthritis Cartilage. 2009 Apr;17(4):518-28
pubmed: 19010695
Mol Genet Genomics. 2007 Mar;277(3):237-48
pubmed: 17131158
PLoS One. 2010 Oct 14;5(10):e13246
pubmed: 20976230
Stem Cell Rev Rep. 2017 Apr;13(2):299-308
pubmed: 27987073
J Orthop Res. 2015 Jan;33(1):84-91
pubmed: 25266708
Stem Cells. 2014 Jun;32(6):1408-19
pubmed: 24578244
Osteoarthritis Cartilage. 2016 May;24(5):868-72
pubmed: 26687821
Biochem Biophys Rep. 2015 Sep;3:38-44
pubmed: 26900604
Ann N Y Acad Sci. 1990;599:45-57
pubmed: 2221676
Stem Cell Rev Rep. 2015 Apr;11(2):242-53
pubmed: 25578634
Annu Rev Biochem. 1991;60:827-61
pubmed: 1883210
Mol Reprod Dev. 1993 Aug;35(4):368-74; discussion 374-5
pubmed: 7691098
Lab Chip. 2015 Mar 7;15(5):1230-49
pubmed: 25598308
Best Pract Res Clin Rheumatol. 2011 Dec;25(6):815-23
pubmed: 22265263
J Orthop Res. 2005 Mar;23(2):425-32
pubmed: 15734258
Stem Cells. 2019 Jan;37(1):65-76
pubmed: 30378731
Cartilage. 2018 Apr;9(2):171-182
pubmed: 29047310
Cell. 2018 Sep 20;175(1):43-56.e21
pubmed: 30241615
Cell. 2016 Jul 14;166(2):451-467
pubmed: 27419872
J Am Soc Nephrol. 2001 Nov;12(11):2400-10
pubmed: 11675416
Stem Cells Transl Med. 2016 Jun;5(6):733-44
pubmed: 27130221
Histochem J. 1999 Sep;31(9):623-32
pubmed: 10579632
Stem Cell Reports. 2015 Mar 10;4(3):404-18
pubmed: 25733017
Arthritis Rheumatol. 2017 Jan;69(1):9-21
pubmed: 27564539
Arthritis Rheum. 2004 May;50(5):1522-32
pubmed: 15146422
Nature. 2003 May 15;423(6937):332-6
pubmed: 12748651
Proc Natl Acad Sci U S A. 2012 Nov 20;109(47):19172-7
pubmed: 23115336
Dev Biol. 2012 Jun 1;366(1):2-9
pubmed: 22230617
Circulation. 2010 Jul 6;122(1):80-7
pubmed: 20606130
Sports Health. 2009 Nov;1(6):461-8
pubmed: 23015907
FASEB J. 2015 Aug;29(8):3399-410
pubmed: 25911615
Dev Dyn. 1995 Jul;203(3):363-76
pubmed: 8589433
Biofabrication. 2013 Jun;5(2):025009
pubmed: 23592549
Stem Cell Res Ther. 2018 Jun 19;9(1):166
pubmed: 29921287
Dis Model Mech. 2013 Jul;6(4):896-904
pubmed: 23751357
Differentiation. 2010 Sep-Oct;80(2-3):155-65
pubmed: 20619527
Nat Biotechnol. 2018 Jun;36(5):411-420
pubmed: 29608179
Osteoarthritis Cartilage. 2015 Nov;23(11):1825-34
pubmed: 26521728
Methods. 2017 May 15;121-122:29-44
pubmed: 28522326
Nat Biotechnol. 2015 Jun;33(6):638-45
pubmed: 25961409
Stem Cell Reports. 2013 Dec 12;1(6):575-89
pubmed: 24371811
Trends Cell Biol. 2001 Mar;11(3):130-5
pubmed: 11306274
Matrix. 1991 Aug;11(4):282-8
pubmed: 1921854
Tissue Eng. 2006 Jul;12(7):1971-84
pubmed: 16889526
Coll Relat Res. 1988 Jul;8(4):277-94
pubmed: 2850886
J Biomech Eng. 1993 Nov;115(4B):460-7
pubmed: 8302026
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Cell. 2007 Nov 30;131(5):861-72
pubmed: 18035408
Arthritis Rheum. 2002 Mar;46(3):694-703
pubmed: 11920405
Circulation. 2010 Mar 9;121(9):1113-23
pubmed: 20176987
Matrix Biol. 2014 Oct;39:5-10
pubmed: 25172830
Matrix Biol. 2018 Oct;71-72:40-50
pubmed: 29800616
Cell Tissue Res. 2002 Jun;308(3):371-9
pubmed: 12107430
Dev Biol. 1989 Feb;131(2):558-66
pubmed: 2643540
FASEB J. 2009 Sep;23(9):3179-92
pubmed: 19447881
Dev Dyn. 2000 Jun;218(2):394-400
pubmed: 10842365
PLoS One. 2017 Jul 6;12(7):e0177962
pubmed: 28683107
Nat Rev Mol Cell Biol. 2013 Jun;14(6):357-68
pubmed: 23673969